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Summary 
Telomerase, a ribonucleoprotein that is capable of synthesizing telomeric repeats,.is expressed in 
germline and malignant cells, and is absent in most normal human somatic cells. The selective 
expression of telomerase has thus been proposed to be a basis for the immortality of the germ- 
line and of malignant cells. In the present study, telomerase activity was analyzed in normal hu- 
man T lymphocytes. It was found that telomerase is expressed at a high level in thymocyte sub- 
populations, at an intermediate level in tonsil T lymphocytes, and at a low to undetectable level in 
peripheral blood T  lymphocytes. Moreover, telomerase activity is highly inducible in periph- 
eral T lymphocytes by activation through CD3 with or without CD28 costimulation, or by stim- 
ulation  with  phorbol myristate acetate  (PMA)/ionomycin.  The induction  of telomerase by 
anti-CD3 plus anti-CD28 (anti-CD3/CD28) stimulation required ILNA and protein synthesis, 
and was blocked by herbimycin A, an inhibitor of Src protein tyrosine kinases.  The immuno- 
suppressive drug cyclosporin A selectively inhibited telomerase induction by PMA/ionomycin 
and by anti-CD3, but not by anti-CD3/CD28.  Although telomerase activity in peripheral T 
lymphocytes was activation dependent and correlated with cell proliferation, it was not cell cy- 
cle phase restricted. These results indicate that the expression oftelomerase in normal human T 
lymphocytes is both developmentally regulated and activation induced. Telomerase may thus 
play a permissive role in T  cell development and in determining the capacity of lymphoid cells 
for cell division and clonal expansion. 
T 
he termini of eukaryotic cell chromosomes consist of 
special structures,  telomeres, which appear to be im- 
portant for the integrity of chromosomes, chromosomal posi- 
tioning in the nucleus, transcriptional activation, and cellu- 
lar  senescence  (1-4).  The  length  of telomeres  decreases 
with increase in age in vivo and with cell division in vitro 
in normal human somatic cells  (5-14).  This phenomenon 
has been attributed to  the  end-replication defect of con- 
ventional DNA polymerase, which results in the loss of ter- 
minal telomeric nucleotides with each chromosomal repli- 
cation  and  may  represent  a  mechanism  for  limiting  the 
cellular replicative hfe span such that cells that have reached 
a critical minimal length of telomeres become incapable of 
further cell division (15, 16). Telomerase is an RNA-depen- 
dent DNA polymerase that is capable of synthesizing telo- 
meric repeats to compensate for the loss  that occurs with 
cell division (17-19).  Analysis  of telomerase expression in 
human cells initially suggested that germline and mahgnant 
cells, but not normal somatic cells, express telomerase, pro- 
viding a basis for the selective immortality of the germline 
and of cancer cells  (20).  However, the recent finding that 
telomerase is expressed at a low level in normal peripheral 
leukocytes, including lymphocytes, and at a relatively high 
level in lymphoid lineage-committed progenitor cells raises 
the question of whether telomerase is widely expressed in 
somatic cells and whether telomerase expression is actively 
regulated in somatic cell lineages (21-23). 
The function oflymphocytes is dependent on a high de- 
gree  of cell division  during  development,  differentiation, 
and activation. T lymphocytes, for instance, are derived from 
T lineage-committed bone marrow progenitor cells, which 
differentiate  within the thymus through an ordered sequence 
of phenotypically distinct  stages:  from immature  double- 
negative  (CD4-CD8-)  to  double-positive  (CD4+CD8 +) 
to  mature  single-positive  (CD4+CD8 -  or  CD4-CD8 +) 
thymocytes that  are  released  into  the  periphery.  During 
intrathymic differentiation, T cells undergo a process of"ed- 
ucation" in which T cells expressing appropriate TCR speci- 
ficities are selected for survival and clonal expansion (24-26). 
Mature T  lymphocytes reside and circulate in the periph- 
ery, where upon encounter of a specific antigen,  those T 
cells  that  recognize the  antigen  are  activated to  undergo 
further differentiation and clonal expansion. Antigen-spe- 
cific activation of T  lymphocytes is  triggered by the  en- 
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MHC ligand complexes, as well as by costimulatory signals, 
such as those delivered through CD28  on the surface of T 
cells  (27-29).  These  receptor/ligand  interactions  induce 
signals that are mediated by a cascade of biochemical events 
that result in the proliferation and differentiation ofT  cells. 
Substantial cell division and  clonal  expansion  are  essential 
for an effective inmmne response. Thus,  lymphocytes pro- 
vide a candidate system in which to study the regulation of 
telomerase  expression  and  the  relationship  between  telo- 
there  length,  telomerase  activity,  and  cellular  replicative 
potential. 
In the present study, we have analyzed telomerase activ- 
ity in T  lymphocytes isolated from the thymus, tonsil, and 
peripheral blood, and  have  found  that  telomerase  expres- 
sion  in  the  human  T  lymphocyte lineage  is  developmen- 
tally regulated.  Moreover,  telomerase activity is  inducible 
in peripheral resting T  cells by activation through CD3 and 
CD28,  and  is  activation/proliferation dependent,  but  not 
cell  cycle phase  restricted.  These  results  indicate  that  the 
expression of telomerase in normal human  T  lymphocytes 
is both  developmentally regulated and  activation-induced, 
and they suggest that telomerase activity may play a role in 
normal imnmne function. 
Materials and Methods 
Isolation of Thymoq,tes and Peripheral Blood T Cells.  Human  thymi 
were obtained during pediatric cardiac surgery on 6-too- to 1  l-yr 
old children. Thymi were minced and pressed through a stainless 
steel sieve. Thymocytes were separated by Ficoll gradient centrifu- 
gation (Organon Teknika, Durham, NC). Subsets of thymocytes 
were further isolated by a combination ofimmunomagnetic bead- 
ing and fluorescent cell sorting. In brief, CD4-CD8-  cells were 
isolated by thc removal of CD4"  and/or CI28 + thymocytes, as 
well as B cells and monocytes, by incubating with antibodies against 
CD4  (516),  CI)8 (B9.8),  CD19  (FMC63), CDllb (NIH1 lb-1), 
and  CI)I.1  (631)3)  (antibodies getleroudy  provided by  Dr.  S. 
Shaw,  National Imtitutes of Health,  Bethesda, MD)  at 4~  for 
l h,  followed  by  goat  anti-mouse  lgG--conjugated  magnetic 
beads (PerSeptive Diagnostics, Cambridge, MA) for another 2-3 h 
at 4~  as previously described  (.30). CD4*CD8 + thymocytes were 
isolated by positive selection using detached antDCD4  or anti- 
CI)8  Ab--coated magnetic beads (Dynat, Great Neck, NY), fol- 
lowing the manufacturer's imtructiom. CD4+CD8 - or CD4-CD8 + 
thymocytes were enriched separately by th~  removal of CI)8-- 
and  CD4*-positive thymocyte~, respe.etively;  followed by posi- 
tive  selection  with  either  anti-CD4  or  anti-CD8  Ab-coated 
magnetic heads or by fluoresr  cell sorting (FACStar  |  Becton- 
Dickinson & Co., Mountain View, CA). Tonsils were obtained 
from tonsillectomies tbr chronic tonsillitis on children and adoles- 
cents 7-16 yr old. Tonsil cells were isolated by the same method 
as isolatiml crf thymocytes, and subpopuht{ons of tonsil T  cells 
were  further  isolated by inamunomagnetic beading as described 
previously (30~. Peripheral blood and buffy coat cells were ob- 
tained from 17 rrormat donors 9-58 yr old from the blood bank at 
NIH Clinical Center, CD4 + and CD8 + T  cells were isolated by 
immunomagnetic beading.. 
Flow  Cytometry  Analysis  of 77~ymoeytes and  Peripheral  T  Cells, 
10" thymocytes~ tonsil or peripheral T lymphocytes were stained 
with  FITC-conjugated anti-CD8  and  PE-conjugated anti-CD4 
antibodies (Caltag Laboratories, San Francisco, CA) according to 
the manufacturer's instructions. Stained cells were then analyzed 
by either FACStar  |  or FACScan  |  (Becton-Dickinson). The pu- 
rity of isolated subsets ofthymocytes, tonsil, and peripheral T lym- 
phocytes was generally >95%. 
Culture,  Activation  and  Inhibition  of Peripheral  7" Cells  In  Vitro. 
Culture of normal CD4 + T cells was carried out as previously de- 
scribed (31,  32).  In brief, 5-10  x  l(Y' peripheral blood CD4*  T 
cells (10  ~' ceUs/ml  in RPMI  1640,  10% fetal bovine serum)  were 
stimulated in vitro with a combination of bead-bound anti-CD3 
and -CD28  mAbs or other specified conditions. For telomerase 
assays, cells were collected as indicated at days 0.5,  I, 2,  3,  6,  or 
12 after stimulation. For experiments assessing the  inhibition of 
stimulation,  inhibitors  were  added  at  the  initiation  of culture 
stimulation, and cells were collected at days 1, 2, and 3. The con- 
centrations of the inhibitors used were as follows: 10 lag/ml acti- 
nomycin D (Sigma hnmunochemicals, St. Louis, MO), 10 I.tg/ml 
cycloheximide (Sigma),  1 I~M herbimycin A  (Calbiochem-Nova- 
biochem, La Jolla, CA), (1.5 ~g/ml cyctosporin A  (Sandoz, East 
Hanover, NJ), and  10 Izg/ml rapamycin (Calbiochem-Novabio- 
chem). In some experiments, 1.9 nM PMA (Sigma) and 0.08 lag/ 
ml ionomycin (iono) (Calbiochem-Novabiochem) were also used 
to stimulate CD4 + T cells. 
Proliferation Assay.  ('.ell proliferation was assayed by pH]thy- 
midine incorporation as previously described (31,  32).  In brief, 
2-5  X  10 s cells were  cultured in  triplicate samples in  flat-bot- 
tomed 96-well microtiter plates in RPMI 1640 medium contain- 
ing 10% fetal bovine serum. Ceils were incubated for 2 d, 1 IxCi of 
[3HIthymidine was added to each well, and incubation was con- 
tinued for another day before harvest.  [3H]thymidine (New En- 
ghmd  Nuclear Corp., Boston,  MA)  incorporation was  measured 
by liquid scintillation counting. 
PCR-based Telometase  Assay,  The telomerasc assay used here 
was  modified fi'om the telomerir  repeats amplification protocol 
(TR.AP)  described previously (20).  Celt extracts were prepared at 
the concentration of 50 /.tl CHAPS  (cholamidopropyl-dimethy- 
tanunonio-propanesulfonate; Calbiochena-Novabiochem) lysis btff  L 
fer per  10  ~' cells.  The  telomerase assay and  PCR  amplification 
steps  were canned out in separate tubes with different buffers to 
improve the telomeras~r efficiency; The telomerase assay was car- 
ried out in an Eppendoff tube ~;ontaining  cell extr~r  from 2  X 
I0  s ce|Is with incubation at 22#G for l h according to a described 
method 03), The amplification of teIomere product was  modi- 
fied by the addition of Taqgtatt (CLONTECH, Palo Alto, CA) 
to the tea~tiorl to increase ~he speci~city ofamplificatfon. In gen- 
eral, one tenth of telomerase lYroduets, equbca|er~ to the extracts 
from  l(r  ~ cells, were used for PCK at described cotiditions with 
27-30 cycles of amplification in a DNA Therrrml Cycler (model 
9600;  Perkin Elmer, Norwalk, CT).  The r~sults showla  used 27 
cycles of amplification unless otherwise indicated, The amplired 
products were then separated on a  12% acrylamide gel (Novex. 
San  Diego, CA), and the. results  were analyzed on a Phospbor- 
Imager (Molecular Dynamics, Inc., Sunnyvale, ('A), To estimate 
telomerase activity, serial  dilutions of cell extracts and different 
PCR cycle numbers were used to determine the linearity of the 
reaction. The controls of the TRAP assay included R.N~e (Boda- 
ringer Mannheim Corp., Indianapolis, IN) treatn~r~ of cell ex- 
tracts, single primor (Ts or Cx alone), and water as templates for 
PCR as described previously (20).  PCR analys~s performed with 
mixtures  of cell  lysate.'r from  inhibRor-treated and  telornerase- 
positive cells demonstrated that mhibitors did not interfere wish 
teiomerase activity or PCR amplificaaon. 
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lation.  CD4 + T  cells were stimulated  with anti-CD3 plus anti- 
CD28, cultured for 3 d, and then subjected to G1 phase synchro- 
nization (34). Cells first were grown in the presence of  2.5 mM of 
thymidine (Sigma) for 24 h, washed twice with Ca  2+- and Mg  2+- 
free PBS (BioWhittaker, Inc., Walkersville,  MD), resuspended in 
conditioned medium with a ratio  of fresh/conditioned media at 
2:1, and incubated for 8 h. Cells were then incubated for 14 hours 
in the presence  of 2  mM hydroxyurea (Sigma),  at which point 
the majority of cells were arrested  in G1  phase.  To obtain cells 
that were enriched in S and G2/M phases, cells were washed out 
of hydroxyurea with PBS,  resuspended in the same fresh/condi- 
tioned medium, and incubated for another 5-6 h at 37~  To ob- 
tain  a high purity of cell  cycle--specific cells, G1,  S,  and  G2/M 
phase  enriched ceils were stained  with 5  t~g/ml Hoechst 33342 
and  0.3  p,g/ml  DiOCs  (3)  (3,3'-dipentyloxacarbocyanine  iodide) 
(Molecular Probes, Eugene,  OR) at 37~  for 1 h (35) and sorted by 
a Coulter Epics Elite  (Coulter Corp., Hialeah,  FL) under UV laser 
light. The purity of  sorted ceils was generally >95%. 
Results 
Telomerase Activity in Human T Lineage Cells.  To assess the 
expression  of telomerase in normal human T  cells,  we ex- 
amined T  lymphocytes isolated from the thymus, tonsil, and 
peripheral  blood. A  high level of telomerase activity, com- 
parable  to that  observed in transformed 293  cells,  was de- 
tected in unseparated thymocytes, intermediate levels in ton- 
sil  T  cells,  and  low  to  undetectable  levels  in  quiescent 
peripheral  blood T  cells  (Fig.  1).  The  levels  of telomerase 
Figure  1.  Telomerase activity in normal human T lymphocytes. Un- 
separated thymocytes,  tonsil, and peripheral T lymphocytes  were analyzed 
for telomerase activity. The ages of the dono~ in the experiment shown 
are: thymus, 11 yr old; tonsil, 12 yr old; peripheral blood, 10 yr old. 293, 
a transformed human kidney cell line that expresses high levels of telo- 
merase and is used here as a positive control; HUVEC,  normal epithelial 
cells isolated from a human umbilical vein used here as a negative control. 
RNase treatment of cell extracts is used here to demonstrate the require- 
ment of P,  NA for telomerase activity. Other negative controls included 
PCP, using either a single primer or PCR using water instead of"  cell ex- 
tracts (data not shown). 
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activity in thymocytes were comparable among five thymi 
from 6-mo- to  11-yr-old donors, and the levels in tonsil T 
cells were comparable among three 7-16-yr-old donors. The 
thymus contains identifiable subpopulations that constitute an 
ordered differentiative pathway. To compare the telomerase 
activity in subpopulations of thymocytes, we isolated and ana- 
lyzed double-negative (CD4-CD8-), double-positive (CD4 + 
CD8§  and single-positive  CD4 +  and  CD8 + populations 
(Fig.  2).  It was  found  that  double-negative,  double-posi- 
tive,  and  CD4 +  single-positive  subpopulations  of thymo- 
cytes  expressed  similar  high  levels  of telomerase  activity 
that  were  -,~27-fold  higher  than  that  of peripheral  blood 
CD4 + T  cells,  while CD8 + single-positive thymocytes ex- 
pressed consistently lower telomerase activity (Fig. 3). Ton- 
sil CD4 + and CD8 + T  lymphocytes expressed an intermedi- 
ate level of telomerase activity that was three- to nine-fold 
higher than that of peripheral blood CD4 + T  cells.  No dif- 
ference  in  telomerase  activity was  apparent  between  CD4  + 
and CD8 + T  lymphocytes that had been isolated from pe- 
ripheral blood (data not shown). 
Induction  of Telomerase Activity in Peripheral Blood CD4 + T 
Cells In  Vitro.  The observed difference in telomerase activ- 
ity in tonsil  and peripheral  blood CD4 +  T  cells suggested 
that  telomerase  activity  may  be  related  to  the  activation 
state  and/or cell cycle stage of T  lymphocytes, since tonsil 
T  lymphocytes are likely to be more highly activated than 
predominantly resting peripheral blood T  lymphocytes. To 
determine  whether  activation  of T  lymphocytes could in- 
duce telomerase expression, CD4 + T  lymphocytes were iso- 
lated from peripheral blood and stimulated with anti-CD3/ 
CD28 or PMA/ionomycin in vitro. Activated lymphocytes 
were  collected at different time  points,  and telomerase ac- 
tivity was analyzed. Activation induced a substantial increase 
in  telomerase  expression  in  T  lymphocytes  under  both 
stimulation  conditions  (Fig.  4).  After anti-CD3/CD28  or 
PMA/ionomycin stimulation,  telomerase  activity was  de- 
tected  as  early  as  day  1,  reached  a  peak  at  days  3-6,  and 
gradually decreased thereafter. Based on serial dilution anal- 
ysis,  the  peak  level  of telomerase  activity  induced  was  at 
least 27-fold greater than  that in unstimulated  T  cells,  and 
was  comparable  to  that  found  in  freshly  isolated  unsepa- 
rated thymocytes (Fig. 5).  Stimulation with anti-CD3 alone 
was  sufficient  to  induce  tetomerase  activity with  response 
kinetics that were somewhat slower than those induced by 
anti-CD3/CD28,  while nonmitogenic stimulation with anti- 
CD28 alone did not induce telomerase expression (Fig. 6). 
Metabolic  and  Signaling  Requirement for  Telomerase  Induc- 
tion.  To  determine  the  metabolic  and  signaling  require- 
ments oftelomerase induction, CD4 + T  lymphocytes were 
stimulated with anti-CD3/CD28  in the presence of meta- 
bolic inhibitors (Fig. 6). Telomerase induction was completely 
blocked by actinomycin D  or cycloheximide, suggesting that 
tLNA and protein syntheses are essential for telomerase in- 
duction. Herbimycin A, an inhibitor ofsrc protein tyrosine 
kinase  and NF-KB  (36--38),  almost completely blocked the 
induction of telomerase,  suggesting that TCR-mediated in- 
duction oftelomerase requires src kinase and/or NF-KB ac- 
tivity. Unseparated thymoeytes 
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Figure 2,  Flow cytometric analysis ofthymocytes. These FACS  |  profiles ofunfractionated and fractionated thymocytes from an 11 yr-old boy are rep- 
resentative of five thymi studied. Cells were stained with FITC-conjugated  anti-CD8 and PE-conjugated  anti-CD4. 
Cyclosporin A  is an immunosuppressive  drug that has been 
shown  to prevent the induction  of T  cell proliferation  and 
cytokine  production  in  response  to  PMA/ionomycin  by 
interfering with the normal function of calcineurin (39-41). 
In  contrast,  stimulation  through  the  CD28  costimulatory 
receptor induces  cyclosporin-resistant  proliferation and  cy- 
tokine  production  (31,  42,  43).  The  induction  of  telo- 
merase  in  T  cells  by  PMA/ionomycin  or  anti-CD3  was 
also blocked by cyclosporin A  treatment, whereas cyclosporin 
A  treatment  had  no  detectable  inhibitory  effect  on  telo- 
merase  induction  when  T  cells  were  stimulated  by  anti- 
CD3 plus anti-CD28  (Fig. 7). 
Telomerase Activity,  Cell  Proliferation, and  Cell  Cycle Phase. 
CD4 +  T  lymphocytes  isolated from peripheral  blood were 
Figure  3.  Comparison  of telomerase activity among the subpopulations  of thymocytes,  tonsil and peripheral  T  Iymphocytes.  Subpopulations  of thy- 
mocytes (CD4-CD8-, CD4+CD8 +, CD4§  -, and CD4-CD8 +) and subsets of tonsil and peripheral blood CD4 + T cells were isolated as described. 
Telomerase  activity was normalized based on equal cell number equivalents, and serial threefold dilutions of cell extracts were assayed to determine  the 
magnitude  of telomerase activity in these cells. 30 rounds of PCR amplification were used in this experiment. 
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and G2/M populations  (Fig. 8). 
Figure 4.  Telomerase induction in peripheral blood CD4 + T lympho- 
cytes by in vitro stimulation with anti-CD3/CD28 and PMA/lonomy- 
cin. This is a representative result of a total of four independent experi- 
ments. Peripheral blood  CD4  + T  lymphocytes isolated from the  same 
individual were stimulated with anti-CD3 plus anti-CD28 or with PMA/ 
ionomycin. 
mainly  resting  Go/G1  cells  that  exhibited  low  telomerase 
activity.  Activation  through  CD3/CD28,  CD3  alone,  or 
PMA/ionomycin  induced  extensive  T  cell  proliferation 
(31,  44),  and as shown above, high levels of telomerase ac- 
tivity.  To  analyze  the  relationship  between  cell  prolifera- 
tion and telomerase induction,  T  cells grown under various 
culture  conditions  were  pulsed  with  [3H]thymidine,  and 
cell proliferation was compared with telomerase activity aSer 
stimulation.  The  induction  of T  cell  DNA  synthesis  by a 
variety of stimuli  and  inhibition  of proliferation  by inhibi- 
tors of metabolism and signal transduction  closely paralleled 
the induction  and inhibition  of telomerase activity by these 
agents  (Table  1),  suggesting  that  telomerase  expression  is 
linked to cell proliferation and entry into the cell cycle. 
To  further  determine  whether  telomerase  expression  in 
CD3/CD28-activated  CD4 +  T  lymphocytes  is  cell  cycle 
phase restricted,  a combination of synchronization and flow 
cytometric sorting was used to isolate highly purified popu- 
lations  of G1,  S,  or G2/M  cell  after 3  d  of culture.  These 
fractionated  populations  were  then  assayed for telomerase 
activity.  All fractions  of CD3/CD28-activated  T  cells had 
equivalently  high  levels  of telomerase,  with  no  significant 
Discussion 
Studies  of telomere  length  in  a  number  of human  so- 
matic cell lineages have demonstrated  that the reduction  of 
telomere  length  occurs progressively with  age  in vivo and 
with  cell  divisions  in  vitro,  leading  to  the  hypothesis  that 
telomeres  serve as  a  biological  clock  of the  replicative  life 
span of normal somatic cells (5-14).  Thus, in the absence of 
telomerase  expression,  somatic  cells  would  undergo  pro- 
gressive  telomere  shortening  with  each  cell  division  until 
the reduction  of telomere length  to a  critical level resulted 
in  exhausting  the  capacity for cell  replication.  In contrast, 
replicative  potential  is not  limited  in  germline  and  malig- 
nant cells because the expression oftelomerase in these cells 
is capable of extending telomeric repeats to compensate for 
replication-associated  telomere shortening.  In an extensive 
survey, telomerase activity has been reported in 86%  (906/ 
1,056)  of all malignant tumors and 0%  (0/78)  of a panel of 
normal  somatic  cells  that  did  not  include  hematopoietic 
and lymphoid cells  (19).  The findings presented  here indi- 
cate that telomerase is expressed in normal somatic cells of 
the  human  T  lymphocyte lineage,  and  that this  expression 
is developmentally regulated. Moreover, these results indicate 
that  telomerase  activity can be induced  in vitro by stimula- 
tion through TCR/CD3  complexes and presumably in vivo 
in peripheral  T  cells.  These results are consistent  with  two 
recent  reports  of telomerase  expression  in  human  periph- 
eral  blood  T  lymphocytes  (22,  23),  and  with  the  demon- 
stration  that  telomerase  activity is  inducible  in  unfraction- 
ated PBMC with mitogen stimulation (23).'Telomerase may 
thus have a broad role in the process of lymphocyte devel- 
opment,  as well  as  in  the  process  of clonal  expansion  and 
the differentiation  of lymphocyte effector functions. 
When human CD4 + naive or memory T  cells were stim- 
ulated cyclically with anti-CD3/CD28  under conditions that 
were  identical  to  those  used  in  the  present  study,  it  was 
found  that  telomere  length  was reduced  progressively at a 
rate of 50-100  bp per cell division,  and that this reduction 
Figure 5.  Comparison of telomerase activity in 
thymocytes and  in  vitro-activated  T  cells. Te- 
lomerase activity was analyzed from cell lysates of 
unseparated thymocytes and of peripheral blood 
CD4 + T lymphocytes 6 d after in vitro activation 
by anti-CD3 plus anti-CD28 or PMA/ionomycin. 
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liferate in response to this stimulation  (13).  Cells harvested 
at various times  during this long-term culture  have subse- 
quently  been  analyzed  for  telomerase  activity,  and  it  has 
been observed that telomerase activity is indeed detectable 
at multiple points during the culture process (data not shown); 
thus, paradoxically, telomere shortening occurs under con- 
ditions in which telomerase activity is detected.  It is possi- 
ble that telomerase provides partial compensation for loss of 
telomeres  during  cell  division,  which  would proceed  at  a 
more  rapid  rate  in  the  absence  of telomerase.  However, 
these findings highlight the need for a definitive determina- 
tion of the role of telomerase in normal somatic cell devel- 
opment and function. Such a determination will require the 
identification of the genes that encode components oftelo- 
merase,  as well as the  ability to manipulate  or target these 
genes in vivo as well as in vitro. The recent cloning of genes 
that encode the RNA  template components of human and 
mouse telomerase will allow the study of the regulation  of 
telomerase RNA  template expression,  as well as the deter- 
mination of the telomerase function in lymphocytes (45, 46). 
Under  the  conditions  of T  cell  activation  and response 
inhibition that were analyzed in the present studies, the reg- 
ulation of telomerase activity closely paralleled that of entry 
into the cell cycle and proliferation.  Stimulation with anti- 
CD3/CD28, anti-CD3 alone, or PMA/ionomycin induced 
high levels of telomerase activity, and these same stimuli are 
also  strong  inducers  of cell  proliferation  (31,  44).  More- 
over,  the  induction  of telomerase  activity  by  anti-CD3/ 
Figure  6.  Induction and inhibition 
of telomerase in CD4 + T lymphocyte 
in  vitro. The results presented are  a 
compilation  of several experiments, 
each of which was carried out at least 
twice  on  independent donors.  Cells 
grown  under  the  various conditions 
were collected at days 1, 2, and 3, and 
the telomerase activity was measured 
by normalization on equal cell number 
equivalents.  Act.  D,  actinomycin D; 
CHX, cycloheximide;  Herbi, herbimy- 
cin A. 
CD28, and the induction of  proliferation by the same stim- 
ulus  are  inhibited  by  the  blockade  of RNA  synthesis  or 
protein  synthesis,  as well  as  the  src kinase  inhibitor  herbi- 
mycin A. Perhaps most strikingly, the induction of  prolifer- 
ation and telomerase  activity by anti-CD3/CD28  is  resis- 
tant  to  cyclosporin  A,  whereas  the  induction  of  both 
proliferation and telomerase activity by anti-CD3  alone or 
PMA/ionomycin  is  sensitive  to  cyclosporin A.  Thus,  al- 
though  anti-CD28  alone  is  not  sufficient  to  induce  telo- 
merase  expression,  signaling through CD28 is  distinct  and 
complementary  to  CD3  signaling,  and  CD28  provides  a 
cyclosporin A-resistant  contribution  to  telomerase  induc- 
tion as well as proliferation. These results suggest that regu- 
lation  of telomerase  expression  in  T  lymphocytes may be 
closely linked to entry into cell cycle, despite a previous re- 
port that cell proliferation per se is not sufficient to induce 
telomerase in normal human fibroblasts (18).  In the present 
study,  strong  telomerase  activity  was  also  observed  in 
CD4-CD8-,  CD4+CD8 +,  and  CD4+CD8 -  human  thy- 
mocytes in the  absence  of in vitro  stimulation,  where  the 
level  of cell  cycling is  relatively  low.  The  nature  of the 
stimuli that might induce or regulate telomerase expression 
in vivo is unclear, but the appearance of telomerase activity 
in multiple developmental fractions ofthymocytes, tonsil, and 
peripheral  blood T  cells  suggests  that  multiple  signals  may 
be capable of influencing telomerase expression. 
Because  telomere  shortening has been  attributed  to  the 
terminal  nucleotide  loss  that  occurs  during  DNA  replica- 
tion, it was of interest to determine whether the activation- 
Figure  7.  Selective  inhibition of telo- 
merase induction under different stim- 
ulation  conditions  by  cyclosporin A. 
Cyclosporin A inhibits in vitro induc- 
tion of telomerase in PMA/ionomycin 
and  anti-CD3,  but  not  in  anti-aCD3/ 
CD28-sfimulated peripheral blood CD4 + 
T lymphocytes.  T cells were collected  at 
days 1, 2, and 3, and the telomerase ac- 
tivity was measured by normalization for 
cell number equivalents. 
2476  Regulated Telomerase  Expression in Human T Cell Lineage Table 1.  Telomerase  Induction and Proliferation of  Human CD4 + 
T Lymphocytes In Vitro 
[3H]thymidine 
incorporation 
Telomerase  Inhibition 
Conditions  activity  cpm  (%) 
Medium  -  168  +  20 
CD3/28"  +  26,192  +  3,265 
CD3/28  +  Act D  -  28 +  4*  100 
CD3/28  +  CHX  -  34 -+ 10  100 
CD3/28  +  Herbi  -  620  -+ 43  98 
CD3/28  +  CsA  +  23,030  -  1,146  12 
CD3  +  20,538  -  2,760 
CD3  +  CsA  -  3,429  +- 403  83 
CD28  -  124  -+ 44 
PMA +  IONO  +  2,286  -  1,046 
PMA +  IONO 1 CsA  -  1,043  -+ 28  63 
*CD3/28,  anti-CD3,  plus  anti-CD28-conjugated  magnetic  beads; 
CD3 or CD28,  anti-CD3 or anti-CD28-conjugated magnetic beads; 
Act D, actinomycin  D, CHX, cycloheximide;  Herbi, herbimycin  A; 
CsA, cyclosporin A; IONO, ionomycin. 
*After treatment with actinomycin D, cycloheximde, or herbimycin A, 
the number of live cells at day 3 was 60-70% of the number of live cells 
in medium, based on trypan blue exclusion. 
induced telomerase activity detected in human T  lympho- 
cytes is cell cycle phase restricted. When activated T  cells were 
synchronized and fractionated on the basis of cell cycle, it 
was  found  that  telomerase  activity was  relatively uniform 
throughout  different phases  of the  cell cycle. Although  it 
cannot be determined whether currently available assays of 
telomerase activity adequately reflect physiologic intracel- 
lular events, these results suggest that telomerase-mediated 
elongation of telomeres may not be strictly linked to DNA 
replication. This result is consistent with the previous find- 
Figure 8.  Telomerase activity in different cell cycle phases. In vitro- 
activated peripheral blood CD4 + T  lymphocytes at different cell cycle 
phases (GI, S, and G2/M), were isolated after 3 d culture by a combina- 
tion of G1 arrest synchronization and.fluorescent cell sorting. Serial three- 
fold dilutions of cell extracts from all three populations were assayed  for 
comparison of telomerase activity. 
ing that telomerase is active in both S and M  phases of cell 
cycles during Xenopus embryogenesis (47).  It is of interest 
that the regulation of telomerase appears to contrast in this 
respect with that  of human  DNA  polymerase ~,  which  is 
tightly regulated by cell cycle (48). 
The  finding that  telomerase  expression  is highly  regu- 
lated, both developmentally and by TCR-mediated activa- 
tion  in  cells of the  human  T  lymphocyte lineage suggest 
that this unique reverse transcriptase may play a significant role 
in normal immune function. As the ability develops to ex- 
perimentally manipulate telomerase gene expression and/or 
enzymatic activity in vivo, it will be of importance to  de- 
termine  what  role  telomerase activity might play in lym- 
phocyte development and differentiation, as well as in cell 
replication,  clonal  expansion,  and  clonal  exhaustion.  As- 
sessment of this possibility will be  critical to  efforts at ex- 
ploring the  potential  for  using  telomerase  inhibition  as  a 
strategy for treating malignant cells without extensive tox- 
icity to normal somatic cell functions. 
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